Although the presence of chemokines such as CCL2 may lead to SMAD3 phosphorylation [65], using a TGF-β1 receptor specific inhibitor, we confirmed that tumor-secreted TGF-β1 is solely responsible for the pSMAD3 response in TCM-treated cells. The gene discussed is CCL2; the disease is neoplasm.